The world of launching a new healthtech product is outrageously complicated in our era. Even large and sophisticated devicemakers can ...

There’s more brewing in US health reform than ever. Is this good or bad for the world of pharma?   ...

Several clients have asked what Commissioner Gottlieb’s departure will mean – to their own industries and other FDA constituencies. To ...

The drug pipeline is filled with high-priced, high-impact cures. Drug price reforms might kill them – is there any cure ...